(Q35709736)

English

Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials.

scientific article published on March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15040646%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

0 references

1 reference

Europe PubMed Central

Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15040646%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Chlamydia pneumoniae

object named as

Chlamydia pneumoniae

1 reference

based on heuristic

inferred from title

Bruce C Carleton

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15040646%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Joseph A Delaney

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15040646%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15040646%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Mahyar Etminan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15040646%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15040646%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15040646%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15040646%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15040646%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

338-343

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15040646%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

HEpiMA: software for the identification of heterogeneity in meta-analysis.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA).

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Antibiotic therapy after acute myocardial infarction: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Induction of macrophage foam cell formation by Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Description and status of the azithromycin and coronary events study (ACES).

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.338.33181

21 January 2018

Identifiers

10.1592/PHCO.24.4.338.33181

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15040646%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15040646%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35709736&oldid=1795455671"